​
​

Xenon Pharmaceuticals Ownership | Who Owns Xenon Pharmaceuticals?

OverviewForecastRevenueFinancialsChartTranscripts

Xenon Pharmaceuticals Ownership Summary

Xenon Pharmaceuticals is owned by 95.51% institutional investors, 0.38% insiders, and 4.12% retail investors. Fmr is the largest institutional shareholder, holding 8.72% of XENE shares. American Funds SMALLCAP World A is the top mutual fund, with 6.93% of its assets in Xenon Pharmaceuticals shares.

XENE Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockXenon Pharmaceuticals95.51%0.38%4.12%
SectorHealthcare Stocks 47.25%8.01%44.75%
IndustryBiotech Stocks 45.35%7.81%46.83%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
American Funds SMALLCAP World A5.25M6.93%93.38K
Vanguard Health Care Inv2.54M3.36%-
Polar Capital Biotech S Inc1.48M1.95%-
Fidelity Select Health Care1.20M1.58%-
Fidelity Advisor Health Care I760.00K1.00%-
Pictet Biotech658.54K0.87%658.54K
Pictet-Biotech P USD652.38K0.86%-3.59K
Polar Capital Healthcare Opports Inc652.16K0.86%-
Strategic Advisers Fidelity US TtlStk628.71K0.83%-
JPMorgan Small Cap Growth A543.55K0.72%179.58K

Recent Insider Transactions

DateNameRoleActivityValue
Mar 08, 2024GAROFALO ELIZABETH A.-Sell$95.58K
Mar 07, 2024ROBIN SHERRINGTON EVP, Strategy & InnovationSell$283.26K
Mar 07, 2024ROBIN SHERRINGTON EVP, Strategy & InnovationSell$47.03K
Mar 07, 2024GANNON STEVEN-Sell$231.25K
Mar 07, 2024GANNON STEVEN-Sell$46.45K

Insider Transactions Trends

DateBuySell
2024 Q2--
2024 Q1-7
2023 Q4-5
2023 Q3-1
2023 Q2-10

XENE Ownership FAQ

Who Owns Xenon Pharmaceuticals?

Xenon Pharmaceuticals shareholders are primarily institutional investors at 95.51%, followed by 0.38% insiders and 4.11% retail investors. The average institutional ownership in Xenon Pharmaceuticals's industry, Biotech Stocks , is 45.35%, which Xenon Pharmaceuticals exceeds.

Who owns the most shares of Xenon Pharmaceuticals?

Xenon Pharmaceuticals’s largest shareholders are Fmr (6.77M shares, 8.72%), Avoro capital advisors (5.67M shares, 7.30%), and Driehaus capital management (4.42M shares, 5.70%). Together, they hold 21.72% of Xenon Pharmaceuticals’s total shares outstanding.

Does Blackrock own Xenon Pharmaceuticals?

Yes, BlackRock owns 2.70% of Xenon Pharmaceuticals, totaling 2.1M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 81.72M$. In the last quarter, BlackRock decreased its holdings by -26.034K shares, a -1.23% change.

Who is Xenon Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Commodore capital lp is Xenon Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 7.33% of its assets in 2.75M Xenon Pharmaceuticals shares, valued at 107.39M$.

Who is the top mutual fund holder of Xenon Pharmaceuticals shares?

American Funds SMALLCAP World A is the top mutual fund holder of Xenon Pharmaceuticals shares, with 6.93% of its total shares outstanding invested in 5.25M Xenon Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools